Compound Radar

Establishment Labs Holdings Inc. (ESTA) Stock Analysis

United States · Healthcare / Medical Devices

Price $75.29
Market cap $2.24B
Next earnings Nov 4, 2026
Entry status Wait $67.80–$70.92

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

41
41/100 Avoid
  • Financial Health 30
  • Profitability 40
  • Business Quality 75
  • Balance Sheet 30
  • Cash Flow 25

Why this rating?

Health 41/100 — Avoid

Strongest Business Quality 75/100
Softest Cash Flow 25/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

Establishment Labs Holdings Inc. (ESTA) is a Medical Devices company in the Healthcare sector. Compound Radar rates Establishment Labs Holdings Inc. 41/100 (Avoid) due to high business quality, strong revenue growth, and elevated leverage.

Investment profile

  • Quality High
  • Growth Strong
  • Balance Sheet Stretched
  • Valuation Elevated

Financial highlights

Valuation

  • Forward P/E 1,254.83
  • EV/Revenue 9.79

Profitability

  • Revenue Growth 31.7%
  • Gross Margin 70.5%
  • Operating Margin -6.4%
  • Net Margin -15.8%
  • ROE -175.3%

Financial strength

  • Cash $71.16M
  • Debt $263.67M
  • Net Cash $-192.52M
  • Free Cash Flow $-57.61M
  • Current Ratio 3.84

Similar companies

Peers in Medical Devices, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Devices →

FAQ

How Compound Radar scores and tracks Establishment Labs Holdings Inc. (ESTA).

View Methodology & FAQ →